Billionaire George Soros Just Bought This Highly Speculative Stock — Should You?

- Home
- TZ Newswire
- Business Features
- ETF's
- Futures
- Options
- Real Estate
- Stocks
- TZ Featured Lists
- TZ Latest News
- TZ Resources
Editorial Archives
Editorial Archives

Published in TZ Latest News 31 May, 2015 by The TZ Newswire Staff

Billionaire George Soros Just Bought This Highly Speculative Stock — Should You?

Billionaire hedge fund manager George Soros bought shares of cancer immunotherapy company Juno Therapeutics in the first quarter. Is this high-risk stock a good buy for average investors?

See also
- Next Article Wall Street Is Too Bullish On These 3 Restaurant Stocks
- Previous Article The Terrifying Method Hackers Used to Steal Nearly 15,000 Tax Refunds From the IRS
Editorial Calender

May 2015

M T W T F S S

1 2 3

4 5 6 7 8 9 10

11 12 13 14 15 16 17

18 19 20 21 22 23 24

25 26 27 28 29 30 31

« Apr Jun »
Recent Tags

Abnormal Returns Active management Asia Brave New World Business Chart.ly Chicago Board Options Exchange CNBC Commodities and Futures Covestor Day Trading Derivatives Equities Exchange Exchange-traded fund Funds Gawker.com GDP Gold Gold as an investment Gross domestic product High-frequency trading Hong Kong Investing Japan Market maker May 6 2010 flash crash Mutual fund National Association of Home Builders New York Mercantile Exchange Option S&P 500 SEC Standard & Poor Stock Stocks and Bonds Stock trader StockTwits Timothy Sykes Tokyo Trade Twitter U.S. Dollar Index U.S. Securities and Exchange Commission United States dollar

The Traderszone Network

Editorial Archives

Published in TZ Latest News 31 May, 2015 by The TZ Newswire Staff

Billionaire George Soros Just Bought This Highly Speculative Stock — Should You?

See also

Editorial Calender

Recent Tags